Approach may offer new way to reverse disability in multiple sclerosis patients
A pair of topical medicines already alleviating skin conditions may prove to have another, even more compelling use: instructing stem cells in the brain to reverse damage caused by multiple sclerosis.
Led by researchers at Case Western Reserve University, a multi-institutional team used a new discovery approach to identify drugs that could activate mouse and human brain stem cells in the laboratory. The two most potent drugs—one that currently treats athlete’s foot, and the other, eczema—were capable of stimulating the regeneration of damaged brain cells and reversing paralysis when administered systemically to animal models of multiple sclerosis. The results were published online (dx.doi.org/10.1038/nature14335) Monday, April 20, in the scientific journalNature.
“We know that there are stem cells throughout the adult nervous system that are capable of repairing the damage caused by multiple sclerosis, but until now, we had no way to direct them to act,” said Paul Tesar, the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics, and associate professor in the Department of Genetics & Genome Sciences at the Case Western Reserve School of Medicine. “Our approach was to find drugs that could catalyze the body’s own stem cells to replace the cells lost in multiple sclerosis.”
The findings mark the most promising developments to date in efforts to help the millions of people around the world who suffer from multiple sclerosis. The disease is the most common chronic neurological disorder among young adults, and results from aberrant immune cells destroying the protective coating, called myelin, around nerve cells in the brain and spinal cord.
Without myelin, neural signals cannot be transmitted properly along nerves; over time, a patient’s ability to walk, hold a cup or even see is inexorably eroded. Current multiple sclerosis therapies aim to slow further myelin destruction by the immune system, but the Case Western Reserve team used a new approach to create new myelin within the nervous system. Their work offers great promise of developing therapies that reverse disabilities caused by multiple sclerosis or similar neurological disorders.
“To replace damaged cells, much of the stem cell field has focused on direct transplantation of stem cell-derived tissues for regenerative medicine, and that approach is likely to provide enormous benefit down the road,” said Tesar, also a New York Stem Cell Foundation Robertson Investigator and member of the National Center for Regenerative Medicine. “But here we asked if we could find a faster and less invasive approach by using drugs to activate native stem cells already in the adult nervous system and direct them to form new myelin. Our ultimate goal was to enhance the body’s ability to repair itself.”
Tesar emphasized that much work remains before multiple sclerosis patients might benefit from the promising approach. Scientists still must find ways to transform the topical medications for internal use and determine their long-term efficacy and potential side effects. That said, using existing, federally approved drugs enhances the likelihood that the compounds can be made safe for human use.
Read more: Drugs stimulate body’s stem cells to replace the brain cells lost in multiple sclerosis
The Latest on: Multiple Sclerosis
[google_news title=”” keyword=”Multiple Sclerosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Multiple Sclerosis
- What Are The Possible Complications Multiple Sclerosis? A Review By Doctorson May 17, 2024 at 2:28 pm
Expert opinion from Ilya AleksandrovskiyM.D., MBA · 5 years of experience · USAMultiple sclerosis complications include the following: 1. Muscle spasms or stiffness 2. Paralysis, most commonly in the ...
- Dufferin County council proclaims May as Multiple Sclerosis Awareness, Sexual Violence Prevention Monthon May 17, 2024 at 8:00 am
May in Dufferin County marks Multiple Sclerosis Awareness and Sexual Violence Prevention Month with proclamations acknowledging the impact of these issues on the community.
- Relapse Risk Higher in Nonactive MS With High-Efficacy Therapy Discontinuationon May 17, 2024 at 6:49 am
In an observational cohort study, researchers assessed whether discontinuation vs continuation of high-efficacy therapies in older patients with nonactive MS is associated with a higher risk for ...
- Targeting Abnormally Active B Cell Metabolism Reduces Multiple Sclerosis Symptomson May 17, 2024 at 1:47 am
Abnormally active metabolism in B cells drives pro-inflammatory responses that lead to myelin being attacked by T cells. By targeting B cell metabolism, multiple sclerosis flare-ups are reduced.
- The Long and Evolving Relationship Between Viruses and Multiple Sclerosison May 15, 2024 at 5:00 pm
Multiple sclerosis (MS) is a demyelinating disorder of unknown etiology, possibly caused by a virus or is virus-triggered. Several viruses, including herpesviruses, were suggested as etiologic ...
- B cells drive responses of other immune cells, and can be modified to prevent Multiple Sclerosis symptomson May 15, 2024 at 5:00 pm
B cells can control responses of myeloid cells through the release of particular cytokines (small proteins that control the growth and activity of cells in the immune system), challenging the ...
- Man to run 145 miles through Nebraska for multiple sclerosison May 14, 2024 at 3:52 pm
Matt Knaggs from Perrysburg, Ohio, will run 145 miles in six days starting in Lincoln on June 15, and then finish on June 20 in Casey, Iowa.
- Sandoz disavows U.K. trade group over dispute about promoting a biosimilar for multiple sclerosison May 13, 2024 at 9:16 am
Sandoz is no longer cooperating with a U.K. industry trade group following a dispute over allegations that the company inappropriately marketed a biosimilar medicine.
- Multiple Sclerosis Diagnoses Are Rising—And Doctors Don’t Know Whyon May 9, 2024 at 2:00 am
Price was referred to another eye specialist, then to a neuro ophthalmologist. After what felt like a never-ending six-hour wait inside a neurologist’s office the following Tuesday, she got a two-word ...
- Multiple Sclerosis Highlights From AAN 2024on May 7, 2024 at 1:55 pm
Highlights in relapsing-remitting multiple sclerosis from AAN 2024 include pregnancy-related considerations, anti-CD20 drug-associated infection, and ocrelizumab safety in Black and Hispanic persons.
via Bing News